Managing myelodysplastic syndromes with supportive therapy in elderly persons

Drug Benefit Trends

Volumn 17, Issue 8, 2005, Pages 341-351

  O'Brien, Judith A ^a   Caro, J Jaime ^a,b  

^a CARO RESEARCH INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Erythropoietin; Myelodysplastic syndromes; Transfusions, blood product

Indexed keywords

ANTIBIOTIC AGENT; AZACITIDINE; CYTOTOXIC AGENT; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IRON;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; AGRANULOCYTOSIS; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTERIAL INFECTION; BLEEDING; BLOOD TRANSFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ELDERLY CARE; ERYTHROCYTE CONCENTRATE; FEMALE; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; IRON THERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; QUALITY OF LIFE; REFRACTORY ANEMIA; SOCIAL SUPPORT; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; UNITED STATES;

EID: 27644459138     PISSN: 10805826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. National Cancer Institute. Myelodysplastic syndromes: treatment. General information. Available at: www.cancer.gov/cancertopics/pdq/treatment/ myelodysplastic/healthprofessional. Accessed July 14, 2005.
2. Castellino SM, Arkansas C, Grawe GH, Cripe T. Myelodysplasia. Available at: www.emedicine. com/ped/topic1526.htm. Accessed July 14, 2005.
3. Greenberg PL, Bennett JM, Bloomfield CD, et al. Myelodysplastic Syndromes: Practice Guidelines in Oncology. Version 1.2005, Jenkintown, Pa: National Comprehensive Cancer Network; 2004.
4. Weisdorf DJ, Oken MM, Johnson GJ, Rydell RE. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia. Br J Haematol. 1983;55:691-700.
5. Gupta P, LeRoy SC, Luikart SD, et al. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications. Leuk Res. 1999;23: 953-959.
6. Pomeroy C, Oken MM, Rydell RE, Filice GA. Infection in the myelodysplastic syndromes. Am J Med. 1991;90:338-344.
7. Italian Cooperative Study Group for rHuEpo in Myelodysplastic Syndromes. A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. Br J Haematol 1998;103:1070-1074.
8. Cheson BD. Chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Semin Oncol 1992;19:85-94.
9. Greenberg PL. Treatment of myelodysplastic syndromes with hemopoietic growth factors. Semin Oncol 1992;19:106-114.
10. Thompson JA, Lee DJ, Kidd P, et al. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. J Clin Oncol. 1989;7:629-637.
11. Ozer H, Armitage JO, Bennett CL, et al; American Society of Clinical Oncology Growth Factors Expert Panel. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. J Clin Oncol. 2000;18:3558-3585.
12. Schiffer CA, Anderson KC, Bennett CL, et al; American Society of Clinical Oncology. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1519-1538.
13. The Food and Drug Administration. FDA approves new drug for bone marrow disease. Available at www.fda.gov/bbs/topics/news/2004/NEW01069.html. Accessed July 14, 2005.
14. Triulzi DJ. Optimizing platelet transfusion therapy. Transfusion Medicine Update. July 1997. Available at: www.itxm.org/TMU1997/tmu797.htm. Accessed July 14, 2005.
15. Sheffield RE, Sullivan SD, Saltiel E, Nishmura L. Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia. Ann Pharmacother. 1997;31:15-22.
16. American Association of Blood Banks. Reimbursement Guide for Blood Products and Services. Version 1.0. Bethesda, Md; American Association of Blood Banks: 2003.
17. Centers for Medicare & Medicaid Services. Addendum B-Payment status by HCPCS code and related information-calendar year 2004. 68 Federal Register 63609 (November 7, 2003).
18. Centers for Medicare & Medicaid Services. Annual Physician Fee Schedule Payment Amount File, July 2004. Available at: www.cms.gov/providers/ pufdownload/#pfspayment. Accessed July 15, 2005.
19. Annual National Laboratory Fee Schedule Payment Amount File. Centers for Medicare and Medicaid Services. 2004. Available at: www.cms.gov/providers/ pufdownload/#labfee. Accessed July 21, 2005.
20. 2003 Drug Topics Red Book. Montvale, NJ: Medical Economics; 2002.
21. St Anthony's 2002 ICD-9-CM Code Book. Reston, Va: Ingenix, Inc; 2001.
22. St Anthony's HCPCS Level II Expert 2004. 15th ed. Reston, Va: Ingenix, Inc; November 2003.
23. American Medical Association. Physicians' Current Procedural Terminology. Chicago: American Medical Association; 2004.
24. California 2001 Discharge Data (Version A) [database on CD-ROM]. Sacramento, Calif: Office of Statewide Health Planning and Development; 2003.
25. Florida 2001 Hospital Patient Data File [database on CD-ROM]. Tallahassee, Fla: State of Florida, Agency for Health Care Administration, State Center for Health Statistics; 2003.
26. Massachusetts Fiscal Year 2001 Acute Hospital Case Mix Data Base, Level III [database on CD-ROM]. Boston: Massachusetts Division of Health Care Finance and Policy; 2003.
27. Maryland 2001 Inpatient Public Use File [database on CD-ROM], Glen Burnie, Md: St Paul Computer Center, Inc; 2003.
28. Washington 2001 CHARS (Comprehensive Hospital Abstract Reporting System) Public Data File [database on CD-ROM]. Olympia, Wash: Washington State Department of Health, Office of Hospital and Patient Data; 2003.
29. Massachusetts Fiscal Year 2002 Emergency Room Case Mix Data Base [database on CD-ROM]. Boston: Massachusetts Division of Health Care Finance and Policy; 2004.
30. Massachusetts Fiscal Year 2001 Observation Unit Case Mix Data Base [database on CD-ROM]. Boston: Massachusetts Division of Health Care Finance and Policy; 2003.
31. Bureau of Labor Statistics. Available at www.bls.gov/cpi/home.htm. Accessed July 15, 2005.
32. The Lewin Group, for the Advanced Medical Technology Association. Ensuring Blood Safety and Availability in the US: Technological Advances, Costs, and Challenges to Payment. Final Report. September 2002. Available at: www. advamed.org/publicdocs/blood-safety-report.pdf. Accessed July 15, 2005.
33. Office of Research, Development, and Information, Centers for Medicare & Medicaid Services. Medicare and Medicaid Statistical Supplement, 2001. Baltimore: US Dept of Health and Human Services; April 2003. Publication 03441.
34. Halls SB, Hanson J. Men's weight chart. Available at: www.halls.md/chart/men-weight-w.htm. Accessed July 15, 2005.
35. Halls SB, Hanson J. Women's weight chart and percentile distribution. Available at: www.halls.md/chart/women-weight-w.htm. Accessed July 15, 2005.
36. Stein RC, Abels RI, Krantz SB. Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood. 1991;78:1658-1663.
37. Seidenfeld J, Aronson N, Piper M, et al, for the Agency for Healthcare Research and Quality. Uses of epoetin for anemia in oncology. In: Evidence Report/Technology Assessment. Number 30. June 2001. AHRQ publication 01-E009.
38. Casadevall N, Durieux P, Dubois S, et al. Erythropoietin plus GCSF in the treatment of anemia in MDS: results of a randomized trial with impact on quality of life and costs. Blood. 2001; 98(suppl 1):848a.
39. O'Brien JA Jr, Jacobs LM, Pierce D. Clinical practice guidelines and the cost of care: a growing alliance. Int J Technol Assess Health Care. 2000;16: 1077-1091.
40. Bennett CL, Somerfield MR, Pfister DG, et al. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. 2003;21:937-941.
41. Romano PS, Mark DH. Bias in the coding of hospital discharge data and its implications for quality assessment. Med Care. 1994;32:81-90.
42. Lloyd SS, Ritchie BP. Physician and coding errors in patient records. JAMA. 1985;254:1330-1336.
43. Quan H, Parsons GA, Ghali WA. Validity of procedure codes in International Classification of Diseases, 9th Revision, Clinical Modification administrative data. Med Care. 2004;42:801-809.
44. American Association of Blood Banks. Comments before the Centers for Medicare & Medicaid Services Advisory Panel on Ambulatory Payment Classification (APC) Groups. August 22, 2003.